Craig-Hallum Downgrades PLAYSTUDIOS to Hold
Craig-Hallum analyst Ryan Sigdahl downgrades PLAYSTUDIOS (NASDAQ:MYPS) from Buy to Hold.
BMO Capital Upgrades Fate Therapeutics to Outperform, Announces $47 Price Target
BMO Capital analyst Etzer Darout upgrades Fate Therapeutics (NASDAQ:FATE) from Market Perform to Outperform and announces $47 price target.
Barclays Maintains Overweight on First American Financial, Lowers Price Target to $83
Barclays analyst Mark Devries maintains First American Financial (NYSE:FAF) with a Overweight and lowers the price target from $87 to $83.
Barclays Maintains Overweight on Fidelity National Finl, Lowers Price Target to $66
Barclays analyst Mark Devries maintains Fidelity National Finl (NYSE:FNF) with a Overweight and lowers the price target from $73 to $66.
Barclays Maintains Overweight on Synchrony Finl, Lowers Price Target to $49
Barclays analyst Mark Devries maintains Synchrony Finl (NYSE:SYF) with a Overweight and lowers the price target from $64 to $49.
Wells Fargo Maintains Overweight on Wolfspeed, Lowers Price Target to $100
Wells Fargo analyst Gary Mobley maintains Wolfspeed (NYSE:WOLF) with a Overweight and lowers the price target from $130 to $100.
Barclays Maintains Overweight on Discover Financial, Lowers Price Target to $140
Barclays analyst Mark Devries maintains Discover Financial (NYSE:DFS) with a Overweight and lowers the price target from $158 to $140.
Wells Fargo Maintains Overweight on Silicon Laboratories, Lowers Price Target to $170
Wells Fargo analyst Gary Mobley maintains Silicon Laboratories (NASDAQ:SLAB) with a Overweight and lowers the price target from $190 to $170.
Wells Fargo Maintains Equal-Weight on Qualcomm, Lowers Price Target to $135
Wells Fargo analyst Gary Mobley maintains Qualcomm (NASDAQ:QCOM) with a Equal-Weight and lowers the price target from $150 to $135.
Wells Fargo Maintains Overweight on NXP Semiconductors, Lowers Price Target to $200
Wells Fargo analyst Gary Mobley maintains NXP Semiconductors (NASDAQ:NXPI) with a Overweight and lowers the price target from $240 to $200.